A Swedish prospective, observational study of health related quality of life over 6 months in patients with overactive bladder starting treatment with Tolterodine SR

Peeker R1, Bergqvist A2

Abstract Category

Quality of Life (QoL)

Abstract 463
Read By Title
Scientific Non Discussion Abstract Session 19
1. Department of Urology, Sahlgrenska University Hospital Goteborg, Goteborg, Sweden., 2. Pfizer AB, Sollentuna, Sweden